These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 5890717)

  • 21. [On several tests of the value of saponin used alone as an adjuvant in the preparation of foot-and-mouth disease vaccine].
    Bayramoglu O; Unlublebici N; Girard HC
    Bull Acad Vet Fr; 1967 Jun; 40(6):283-6. PubMed ID: 4305068
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effectiveness of anti-foot-and-mouth disease GOA-formol vaccine with saponin].
    Antoniuk VP; Kruglikov BA; Barbashov VP; Bashkatov SF; Chernyshova GT
    Veterinariia; 1972 Sep; 9():61-2. PubMed ID: 4667544
    [No Abstract]   [Full Text] [Related]  

  • 23. [The effectiveness of vaccination to prevent foot and mouth disease in several species].
    Orsel K
    Tijdschr Diergeneeskd; 2008 Jan; 133(1):14-6. PubMed ID: 18260556
    [No Abstract]   [Full Text] [Related]  

  • 24. Immune response of pigs to inactivated foot-and-mouth disease vaccines. Response to DEAE-dextran and saponin adjuvanted vaccines.
    Anderson EC; Masters RC; Mowat GN
    Res Vet Sci; 1971 Jul; 12(4):351-7. PubMed ID: 5558542
    [No Abstract]   [Full Text] [Related]  

  • 25. The influence of aluminium hydroxide content, dose volume and the inclusion of saponin on the efficacy of inactivated foot-and-mouth disease vaccines.
    Hyslop NS; Morrow AW
    Res Vet Sci; 1969 Mar; 10(2):109-20. PubMed ID: 5818030
    [No Abstract]   [Full Text] [Related]  

  • 26. [Trials of vaccination ff swine against foot-and-mouth disease virus type O with a live vaccine obtained through mouse brain passage].
    Benndorf E
    Arch Exp Veterinarmed; 1966 Mar; 20(1):151-6. PubMed ID: 4293435
    [No Abstract]   [Full Text] [Related]  

  • 27. Cedivac-FMD can be used according to a marker vaccine principle.
    Chénard G; Selman P; Dekker A
    Vet Microbiol; 2008 Apr; 128(1-2):65-71. PubMed ID: 18035508
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The preparation and use of convalescent blood in foot-andmouth disease].
    Malakhova TI; Shevtsova IN; Zaĭtseva LP; Chudnovskiĭ EI
    Veterinariia; 1966 Mar; 43(3):40-2. PubMed ID: 6011540
    [No Abstract]   [Full Text] [Related]  

  • 29. [Saponin vaccine from the Ai variant of lapinized foot-and-mouth disease virus].
    Andreev EV; Boĭko AA; Lutsevich FF; Filatov IP; Mikhaĭliuk AP
    Veterinariia; 1968 Jan; 45(1):28-31. PubMed ID: 4312579
    [No Abstract]   [Full Text] [Related]  

  • 30. [Course and duration of anti-foot-and-mouth disease post-vaccination immunity in pluri-vaccinated cattle].
    Fédida M; Dannacher G; Coudert M; Peillon M; Lucam F
    Bull Off Int Epizoot; 1972; 77(5):1005-27. PubMed ID: 4660707
    [No Abstract]   [Full Text] [Related]  

  • 31. [Studies of anti-foot-and-mouth disease vaccines for swine prepared with various adjuvants].
    Mitev G; Tekerlekov P; Zhlebnikov Z; Shopov I
    Vet Med Nauki; 1973; 10(1):55-60. PubMed ID: 4370838
    [No Abstract]   [Full Text] [Related]  

  • 32. [Anaphylaxis and other disorders in connection with vaccination against foot-and-mouth disease].
    Andres J
    Schweiz Arch Tierheilkd; 1967 Jun; 109(6):338-42. PubMed ID: 5628618
    [No Abstract]   [Full Text] [Related]  

  • 33. Saponin adjuvants. IV. Evaluation of the adjuvant quil A in the vaccination of cattle against foot-and-mouth disease.
    Dalsgaard K; Jensen MH; Sorensen KJ
    Acta Vet Scand; 1977; 18(3):349-60. PubMed ID: 910657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Saponin adjuvants. VI. The adjuvant activity of quil A in trivalent vaccination of cattle and guinea pigs against foot-and-mouth disease.
    Dalsgaard K; Jensen MH
    Acta Vet Scand; 1977; 18(3):367-73. PubMed ID: 910658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Foot-and-mouth disease and the use of face masks.
    Jones TO
    Vet Rec; 2007 Dec 22-29; 161(25):863-4. PubMed ID: 18156598
    [No Abstract]   [Full Text] [Related]  

  • 36. [Experience in eradicating foot-and-mouth disease in the Belorussian SSR].
    Demidov VA; Kovalev NA; Grechishkin MD
    Veterinariia; 1968 Mar; 45(3):30-2. PubMed ID: 4243882
    [No Abstract]   [Full Text] [Related]  

  • 37. [Control measures against foot-and-mouth disease in pigs].
    Brühann W
    Dtsch Tierarztl Wochenschr (1946); 1963 May; 70(9):229-35. PubMed ID: 5896659
    [No Abstract]   [Full Text] [Related]  

  • 38. Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak response.
    Golde WT; Pacheco JM; Duque H; Doel T; Penfold B; Ferman GS; Gregg DR; Rodriguez LL
    Vaccine; 2005 Dec; 23(50):5775-82. PubMed ID: 16153756
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Control of efficacy of foot-and-mouth disease vaccine prepared for swine].
    Fédida M; Coudert M; Dannacher G; Peillon M
    Bull Off Int Epizoot; 1972; 77(5):821-38. PubMed ID: 4676699
    [No Abstract]   [Full Text] [Related]  

  • 40. High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus.
    Brehm KE; Kumar N; Thulke HH; Haas B
    Vaccine; 2008 Mar; 26(13):1681-7. PubMed ID: 18313814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.